advertisement

Diabetes

28 June 2011

New hurdle for diabetes vaccine

An experimental vaccine to prevent progression of type 1 diabetes failed at the second step of the three-phase trial process, doctors said in a study.

An experimental vaccine to prevent progression of type 1 diabetes failed at the second step of the three-phase trial process, doctors said in a study reported online by The Lancet.

The idea was that by vaccinating patients with GAD, this would teach the immune system's T cells to tolerate the enzyme.

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.

Ask the Expert

Diabetes expert

Dr. May currently works as a fulltime endocrinologist and has been in private practice since 2004. He has a variety of interests, predominantly obesity and diabetes, but also sees patients with osteoporosis, thyroid disorders, men's health disorders, pituitary and adrenal disorders, polycystic ovaries, and disorders of growth. He is a leading member of several obesity and diabetes societies and runs a trial centre for new drugs.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules